Curtis Gale Oltmans insider trades

Open-market stock purchases and sales by Curtis Gale Oltmans, Chief Legal Officer at Fulcrum Therapeutics, Inc, from SEC Form 4 filings since Aug 15, 2017.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -59%.

Recent trades

DateStockTradeValue
Feb 2, 2026FULC Fulcrum Therapeutics, IncBought (not open market)—
Dec 15, 2025FULC Fulcrum Therapeutics, IncSold$44.6K

Companies traded

  • FULC Fulcrum Therapeutics, Inc: 1 buy, 1 sale, last Feb 2, 2026
  • ATXI Avenue Therapeutics, Inc: other filings, last Sep 23, 2024
  • ARRY Array Biopharma Inc: 4 sales, last Feb 5, 2019

Get free alerts when Curtis Gale Oltmans files a new trade →